Novartis AG to Discuss Beovu® FDA Approval Investor Call Transcript
Good morning and good afternoon, and welcome to the Beovu FDA Approval Investor Call. (Operator Instructions) and the conference is being recorded. (Operator Instructions) A recording of the conference call, including the Q&A session, are available on our website shortly after the call ends. (Operator Instructions)
With that, I would like to hand it over to Samir Shah, Global Head, Investor Relations. Please go ahead, sir.
Thank you very much. And good morning and good afternoon, everybody. It's a pleasure to talk to you today about our Beovu FDA approval. And I'd like to thank you all for taking the time to listen to this investor call.
Before we start, I'll just read the safe harbor statement. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statement. Please refer to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
